Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial journalArticle 2015 Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M.
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal type journalArticle 2015 Michot, J. M.; Mazeron, R.; Danu, A.; Lazarovici, J.; Ghez, D.; Antosikova, A.; Willekens, C.; Chamseddine, A. N.; Minard, V.; Dartigues, P.; Bosq, J.; Carde, P.; Koscielny, S.; De Botton, S.; Ferme, C.; Girinsky, T.; Ribrag, V.
All simulation models of breast cancer are wrong but some are useful journalArticle 2018 Michiels, S.; Delaloge, S.
Late toxicity of brachytherapy after female genital tract tumors treated during childhood: Prospective evaluation with a long-term follow-up journalArticle 2015 Levy, A.; Martelli, H.; Fayech, C.; Minard-Colin, V.; Dumas, I.; Gensse, M. C.; Le Deley, M. C.; Oberlin, O.; Haie-Meder, C.
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma journalArticle 2018 Grill, J.; Massimino, M.; Bouffet, E.; Azizi, A. A.; McCowage, G.; Canete, A.; Saran, F.; Le Deley, M. C.; Varlet, P.; Morgan, P. S.; Jaspan, T.; Jones, C.; Giangaspero, F.; Smith, H.; Garcia, J.; Elze, M. C.; Rousseau, R. F.; Abrey, L.; Hargrave, D.; Vassal, G.
Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration journalArticle 2016 Dourthe, M. E.; Ternes, N.; Gajda, D.; Paci, A.; Dufour, C.; Benhamou, E.; Valteau-Couanet, D.
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma journalArticle 2017 Bacorro, W.; Escande, A.; Temam, S.; Dumas, I.; Routier, E.; Gensse, M. C.; Blanchard, P.; Janot, F.; Mateus, C.; Tao, Y.; Robert, C.; Deutsch, E.; Haie-Meder, C.; Chargari, C.
Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas journalArticle 2019 Petit, C.; Blanchard, P.; Pignon, J. P.; Lueza, B.
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials journalArticle 2018 Rotolo, F.; Paoletti, X.; Michiels, S.
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe journalArticle 2015 Bölling, T.; Braun-Munzinger, G.; Burdach, S.; Calaminus, G.; Craft, A.; Delattre, O.; Deley, M. C.; Dirksen, U.; Dockhorn-Dworniczak, B.; Dunst, J.; Engel, S.; Faldum, A.; Fröhlich, B.; Gadner, H.; Göbel, U.; Gosheger, G.; Hardes, J.; Hawkins, D. S.; Hjorth, L.; Hoffmann, C.; Kovar, H.; Kruseova, J.; Ladenstein, R.; Leuschner, I.; Lewis, I. J.; Oberlin, O.; Paulussen, M.; Potratz, J.; Ranft, A.; Rössig, C.; Rübe, C.; Sauer, R.; Schober, O.; Schuck, A.; Timmermann, B.; Tirode, F.; van den Berg, H.; van Valen, F.; Vieth, V.; Willich, N.; Winkelmann, W.; Whelan, J.; Womer, R. B.
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials journalArticle 2015 Paoletti, X.; Ezzalfani, M.; Le Tourneau, C.
Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome journalArticle 2015 Patrikidou, A.; Brureau, L.; Casenave, J.; Albiges, L.; Di Palma, M.; Patard, J. J.; Baumert, H.; Blanchard, P.; Bossi, A.; Kitikidou, K.; Massard, C.; Fizazi, K.; Blanchet, P.; Loriot, Y.
Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice journalArticle 2016 Michiels, S.; Ternes, N.; Rotolo, F.
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial journalArticle 2016 Krol, A.; Ferrer, L.; Pignon, J. P.; Proust-Lima, C.; Ducreux, M.; Bouche, O.; Michiels, S.; Rondeau, V.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study journalArticle 2015 Vale, C. L.; Rydzewska, L. H.; Rovers, M. M.; Emberson, J. R.; Gueyffier, F.; Stewart, L. A.; Cochrane, I. P. D. Meta-analysis Methods Group
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors journalArticle 2018 Guerrero-Zotano, A.; Stricker, T.; Formisano, L.; Hutchinson, K. E.; Stover, D. G.; Lee, K. M.; Schwarz, L. J.; Giltnane, J. M.; Estrada, M. V.; Jansen, V. M.; Servetto, A.; Gavilá, J.; Pérez-Fidalgo, J. A.; Lluch, A.; Llombart-Cussac, A.; Bayar, M. A.; Michiels, S.; Andre, F.; Arnedos, M.; Guillem, V.; Ruiz-Simon, A.; Arteaga, C. L.
A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events journalArticle 2015 Li, J.; Poursat, M. A.; Drubay, D.; Motz, A.; Saci, Z.; Morillon, A.; Michiels, S.; Gautheret, D.
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors journalArticle 2017 Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.
Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models journalArticle 2016 Ternes, N.; Rotolo, F.; Michiels, S.
Radiation-induced neurocognitive dysfunction in head and neck cancer patients journalArticle 2017 De Felice, F.; Blanchard, P.
Impact of Skin Toxicities Associated with Targeted Cancer Therapies on Body Image: A Prospective Study journalArticle 2016 Charles, C.; Razavi, D.; Bungener, C.; Mateus, C.; Lanoy, E.; Verschoore, M.; Dauchy, S.; Robert, C.
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer journalArticle 2018 Rotolo, F.; Zhu, C. Q.; Brambilla, E.; Graziano, S. L.; Olaussen, K.; Le-Chevalier, T.; Pignon, J. P.; Kratzke, R.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Michiels, S.; Tsao, M. S.
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status journalArticle 2015 Messai, Y.; Gad, S.; Noman, M. Z.; Le Teuff, G.; Couve, S.; Janji, B.; Kammerer, S. F.; Rioux-Leclerc, N.; Hasmim, M.; Ferlicot, S.; Baud, V.; Mejean, A.; Mole, D. R.; Richard, S.; Eggermont, A. M.; Albiges, L.; Mami-Chouaib, F.; Escudier, B.; Chouaib, S.
[Data sources, the data used, and the modality for collection] journalArticle 2018 Mercier, G.; Costa, N.; Dutot, C.; Riche, V. P.
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial journalArticle 2017 Belin, L.; Kamal, M.; Mauborgne, C.; Plancher, C.; Mulot, F.; Delord, J. P.; Gonçalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Trédan, O.; Ricci, F.; Alt, M.; Loirat, D.; Sablin, M. P.; Paoletti, X.; Servois, V.; Le Tourneau, C.
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia journalArticle 2015 Selimoglu-Buet, D.; Wagner-Ballon, O.; Saada, V.; Bardet, V.; Itzykson, R.; Bencheikh, L.; Morabito, M.; Met, E.; Debord, C.; Benayoun, E.; Nloga, A. M.; Fenaux, P.; Braun, T.; Willekens, C.; Quesnel, B.; Ades, L.; Fontenay, M.; Rameau, P.; Droin, N.; Koscielny, S.; Solary, E.; Francophone Myelodysplasia, Group
The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence journalArticle 2016 Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C.
Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study journalArticle 2018 Fresneau, B.; Orbach, D.; Faure-Conter, C.; Sudour-Bonnange, H.; Vérité, C.; Gandemer, V.; Pasquet, M.; Fasola, S.; Rome, A.; Raimbault, S.; Martelli, H.; Frappaz, D.; Le Teuff, G.; Patte, C.
The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has journalArticle 2015 Guichard, M.; D'Andon, A.; Rumeau Pichon, C.; Borget, I.
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients journalArticle 2016 Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F.
biospear: an R package for biomarker selection in penalized Cox regression journalArticle 2018 Ternes, N.; Rotolo, F.; Michiels, S.
Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution journalArticle 2016 Proust-Houdemont, S.; Pasqualini, C.; Blanchard, P.; Dufour, C.; Benhamou, E.; Goma, G.; Semeraro, M.; Raquin, M. A.; Hartmann, O.; Valteau-Couanet, D.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer journalArticle 2016 Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report journalArticle 2016 Kager, L.; Whelan, J.; Dirksen, U.; Hassan, B.; Anninga, J.; Bennister, L.; Bovee, Jvmg; Brennan, B.; Broto, J. M.; Brugieres, L.; Cleton-Jansen, A. M.; Copland, C.; Dutour, A.; Fagioli, F.; Ferrari, S.; Fiocco, M.; Fleuren, E.; Gaspar, N.; Gelderblom, H.; Gerrand, C.; Gerss, J.; Gonzato, O.; van der Graaf, W.; Hecker-Nolting, S.; Herrero-Martin, D.; Klco-Brosius, S.; Kovar, H.; Ladenstein, R.; Lancia, C.; LeDeley, M. C.; McCabe, M. G.; Metzler, M.; Myklebost, O.; Nathrath, M.; Picci, P.; Potratz, J.; Redini, F.; Richter, G. H. S.; Reinke, D.; Rutkowski, P.; Scotlandi, K.; Strauss, S.; Thomas, D.; Tirado, O. M.; Tirode, F.; Vassal, G.; Bielack, S. S.
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma journalArticle 2019 Du, C.; Blanchard, P.; Even, C.; Boros, A.; Gorphe, P.; Breuskin, I.; Baste-Rotllan, N.; Nguyen, F.; Ruffier, A.; Bidault, F.; Billard, C.; Janot, F.; Mirghani, H.; Temam, S.; Tao, Y.
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer journalArticle 2018 Criscitiello, C.; Bayar, M. A.; Curigliano, G.; Symmans, F. W.; Desmedt, C.; Bonnefoi, H.; Sinn, B.; Pruneri, G.; Vicier, C.; Pierga, J. Y.; Denkert, C.; Loibl, S.; Sotiriou, C.; Michiels, S.; André, F.
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F.
Percutaneous bone biopsies: comparison between flat-panel cone-beam CT and CT-scan guidance journalArticle 2015 Tselikas, L.; Joskin, J.; Roquet, F.; Farouil, G.; Dreuil, S.; Hakime, A.; Teriitehau, C.; Auperin, A.; de Baere, T.; Deschamps, F.
Mining the coding and non-coding genome for cancer drivers journalArticle 2015 Li, J.; Drubay, D.; Michiels, S.; Gautheret, D.